Clinical Trial Results:
Pilot study to evaluate the efficacy, safety and tolerability of ammonium chloride in terms of protection from hepatotoxic effect of Hep C infection and normalisation of altered liver parameters, in a 3-month treatment, during the standard of care combination therapy of relapsed chronic hepatitis C patients.
Summary
|
|
EudraCT number |
2009-017740-13 |
Trial protocol |
GR |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
24 Nov 2021
|
First version publication date |
24 Nov 2021
|
Other versions |
|
Summary report(s) |
20130404-csr-101-f-1-0 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.